Clinical trial
Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After…
NCT00214201 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214201 |
|---|---|
| Title | Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation |
| Official title | Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Primary Renal Transplant |
| Intervention type | Drug |
| Interventions | Calcineurin inhibitor withdrawal |
| Enrollment | 40 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: